Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A great reminder that the deal never went through. Was never put into effect!
We shall see what happens tomorrow morning. But whatever happens. Holding through 2021. Best shot at realistic gains.
Bought more!
Under DSHEA, a firm is responsible for determining that the dietary supplements it manufactures or distributes are safe and that any representations or claims made about them are substantiated by adequate evidence to show that they are not false or misleading. This means that dietary supplements do not need approval from FDA before they are marketed. Except in the case of a new dietary ingredient, where pre-market review for safety data and other information is required by law, a firm does not have to provide FDA with the evidence it relies on to substantiate safety or effectiveness before or after it markets its products.Also, manufacturers need to register themselves pursuant to the Bioterrorism Act with FDA before producing or selling supplements.
https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
Interesting only if it was new. But this is not new. Ingredients have some well known positive effects. Nothing tsoi is reporting is new. Just combined ingredients and referencing older studies. Only thing they are trying to sell is old news and shares. There is no major breakthrough. These ingredients have been studied for decades.
Not working, smart people know it's a dietary supplement. Ingredients on the market already with already wellknown effects. Share price will continue to decline as the end of the dilutionary practices is nowhere in sight.
I guess you don't understand sarcasm. Why not just use humans with certain issues and see if this already marketed formula works at all? Oh, that would mean an actual study and not rehashing older studies performed by others on the already well known and marketed elsewhere ingredients. Seems they are having problems in just getting 500 healthy people for the current study. Oh well. Just p r and sell more shares.
Of course this comment of yours is genius.
FDA does not do anything with neutraceuticals ie dietary supplements.
Yay for the animals with memory loss. Geez! Since the supplement is already marketed and supposedly safe for human consumption why waste time on animals? Mmmmmm
That's the best case scenario? An expectation of "soon" with nothing finalized through the end of the year? So much for conducting a trial now with results in November.
Whats the worst case scenario? Oh nevermind, already know what that may be.
Emergency use approval? That's a joke right? The product is already on the market. Its a dietary supplement. There is zero reason to even consider that as it doesn't apply. Its all bs.
Tomorrow should be interesting. The day before earnings release/updates. Should have a good idea what the market is looking for on Thursday based on tomorrows activity.
Are you referring to the processor or 4kids?
Exactly, you have to look at block 3. The transaction code!. A = Awarded
What matters is that since the company has no money they take shares. Those shares cause dilution. Eventually the AS will have to be raised to continue to pay the two. Zero free cash flow is a detriment to all shareholders.
17 CFR § 240.16b-3 - Transactions between an issuer and its officers or directors.
(d) Acquisitions from the issuer. Any transaction, other than a Discretionary Transaction, involving an acquisition from the issuer (including without limitation a grant or award), whether or not intended for a compensatory or other particular purpose, shall be exempt if:
(1) The transaction is approved by the board of directors of the issuer, or a committee of the board of directors that is composed solely of two or more Non-Employee Directors;
(2) The transaction is approved or ratified, in compliance with section 14 of the Act, by either: the affirmative votes of the holders of a majority of the securities of the issuer present, or represented, and entitled to vote at a meeting duly held in accordance with the applicable laws of the state or other jurisdiction in which the issuer is incorporated; or the written consent of the holders of a majority of the securities of the issuer entitled to vote; provided that such ratification occurs no later than the date of the next annual meeting of shareholders; or
(3) The issuer equity securities so acquired are held by the officer or director for a period of six months following the date of such acquisition, provided that this condition shall be satisfied with respect to a derivative security if at least six months elapse from the date of acquisition of the derivative security to the date of disposition of the derivative security (other than upon exercise or conversion) or its underlying equity security.
Rule 16b-3 Transaction Codes
A — Grant, award or other acquisition pursuant to Rule 16b-3(d)
D — Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F — Payment of exercise price or tax liability by delivering or with holding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
I — Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
M — Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
https://www.sec.gov/edgar/searchedgar/ownershipformcodes.html
So a 500 person trial announced how long ago, still recruiting, and no way of knowing how to determine its success or failure because the trial is done on healthy people, is supposed to do what? Sell shares thats all. But I'm sure another billion shares will be authorized right before the announced results.
Just needs to make the rounds. Was barely an announcement. This will all be made well known come 6 August.
Whether they sell or not is meaningless. Awarded shares come from AS and is put in the OS. Restricted or not, its diluting present shareholders value. Thus it is inevitable that the pps drops. Since he hasn't had to pay for them its not much of an issue for him.
You'd have to ask them. So how many employees does Therapeutic Solutions International have presently on the payroll?
Have you ever been to Vietnam? I have, everything from streets to shops excessively crowded. No reason for the virus not to spread to so many people. I will say they are the nicest people I've met. Especially in the hotels and restaurants. If you haven't been I highly recommend going once the pandemic is over.
Doesn't answer the question. Why would anyone invest in a company where they can't find basic information? If its just the CEO and Ichim, makes one wonder where all this money for shares is going.
How many employees does Therapeutic Solutions International have?
Anticipation will bring the pps over 5 possibly 6 the closer we get to the release. Then who knows what will happen short term. Longer term with what they already have in berotralstat, its a no brainer at this price to buy. Just look at the anslysts target price. Professionals keeping a very close eye on biocryst this week.
This is funny. Even his son knows laborsmart is broken. Wonder if he knows why....
Ryan Schadel
@CRyanSchadel
·
Aug 1
Son: Dad we need a bigger pool
Me: Buddy thats like $100k and we dont have that right now.
Son: Yea but you are going to fix laborsmart and then you will.
Smart kid.
Outside of these message boards there is NO interest. Falling volume, post pump and dump, very predictable.
The body pisses out a majority of supplements taken. Sounding like snake oil salesman again. Guess the govt feels the same way...no interest!
So's a blueberry! But quadramune is a diet supplement. To claim otherwise is fraud.
The difference is minor and only listed to sell shares. If this had any serious ramifications it wouldn't be associated with a stinky pinky share selling operation.
Excellent but not new. Again no patent required!
Exactly, one doesn't need a patent to sell the ingredients. Its all on the market. We all have known about anti oxidants for decades. This is nothing new. Like eat well and exercise and you'll be healthier. Being healthier allows a person to fight off viruses better. This is nothing new, but this company is manipulating people to buy dumped shares and a product that does nothing more than all other decade old products. This is nothing new!
Still amazing that any legitimate ceo follows a stock message board. Reeks of stinky pinky bs. Then why not conduct a reverse split and get the share price over a dollar and list on NYSE? Also get a real business loan and stop diluting shareholders. To be on the pinks is not anything to be proud of. Rehashing old studies to legitimize the dilution is sad. To use the covid 19 scare to push decades old research while trying to fleece people is incorrigible. Oh time will tell and Karma will reign!
Here's one of many sources for pterostilbene.
https://jarrowonline.com/products/pterostilbene-50-mg-60-veggie-caps?variant=13023755927595¤cy=USD&utm_medium=product_sync&utm_source=google&utm_content=sag_organic&utm_campaign=sag_organic&gclid=Cj0KCQjwyJn5BRDrARIsADZ9ykFs8n5bT9G8eYX2KDx20_rNqFjwuKbRLd9AHjNM-kcrmPHpsTqE950aAlfSEALw_wcB
In other words. If you have cancer and going through treatment. Eat blueberries. Below is the beginning of a 2013 written paper. All healthful foods have positive aspects. Touting an invention or patent on effects of a blueberry is laughable as products/supplements are on the market today. That "patent" really does mean nothing.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649683/
Pterostilbene (trans-3,5-dimethoxy-4-hydroxystilbene) is a naturally derived compound found primarily in blueberries and Pterocarpus marsupium (PM) heartwood [1, 2]. The amount of daily pterostilbene consumption varies according to dietary fruit intake, and it has been estimated that pterostilbene content per blueberry varies from 99?ng to 520?ng/gram depending on the type of berry ingested [3, 4]. Substantial evidence suggests that pterostilbene may have numerous preventive and therapeutic properties in a vast range of human diseases that include neurological, cardiovascular, metabolic, and hematologic disorders. Further benefits of pterostilbene have been reported in preclinical trials, in which pterostilbene was shown to be a potent anticancer agent in several malignancies [5]. Pterostilbene is structurally similar to resveratrol, a compound found in red wine that has comparable antioxidant, anti-inflammatory, and anticarcinogenic properties; however, pterostilbene exhibits increased bioavailability due to the presence of two methoxy groups which cause it to exhibit increased lipophilic and oral absorption (Figure 1) [6–10]. In animal studies, pterostilbene was shown to have 80% bioavailability compared to 20% for resveratrol making it potentially advantageous as a therapeutic agent [6].
True, but these are not usual times. biocryst will save money by not doing a separate PR. the 10q will have all information up to the date of filing. The "subsequent events" is what I will look at first,
Just a short few days til the sudden explosion. Will be very interesting on getting the 6 August update.
Sure, lets take lessons from the UK. Really like the paragraph on the virus being racist. But this is the most important point you should highlight!
Are you sure you're not being scammed?
100 percent correct. Dilution is massive here. Only ones benefitting is management. Every single ingredient in quad is already available on the market. The covid story is a crock. Just wait and see.
Look at volume. Surprisingly a few bagholders had a few dollars to spend. Watch for the continued decline next week. Painting up 95 percent of the time. Thats desperation on those that refuse to see the reality because they married the stock. Ask the ones that bought at .015 and see how they feel.